A four-stage progression model identifies potential targets for neurogenic pulmonary edema managementNew model reveals four stages of neurogenic pulmonary edema

Frontiers in Medicine Published July 4, 2026 DOI ↗ Editorial oversight: Dr. Ji-eun Park, MD · Brain, Mind & Pain

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway

Note that this theoretical model of NPE progression suggests specific stages for future research and intervention targets.

This narrative review outlines a theoretical framework for the pathophysiology of neurogenic pulmonary edema (NPE). The authors synthesize a four-stage progression model: sympathetic storm initiation, pulmonary vascular barrier disruption involving Piezo channel activation and angiotensin II-norepinephrine synergy, inflammatory amplification through loss of cholinergic anti-inflammatory reflex, and systemic progression via gut-lung axis dysregulation.

Based on this model, the review proposes three testable predictions for future research. These include identifying specific neural projections that cause severe NPE, utilizing TRPA1+ dorsal root ganglion neurons to attenuate sympathetic outflow, and enhancing alpha7 nicotinic acetylcholine receptor signaling to mitigate systemic inflammation.

Because this is a narrative review based on a theoretical framework, no primary clinical data or trial results are reported. The findings suggest potential for stage-specific interventions, such as early sympathetic blockade or mid-phase anti-inflammatory strategies. However, the evidence level is low as these conclusions do not currently have empirical support from clinical trials.

When a severe brain injury strikes, the body can react in a way that floods the lungs with fluid. This is neurogenic pulmonary edema (NPE), a dangerous condition that can make it hard to breathe. Until now, doctors have had limited understanding of how it unfolds.

A new narrative review proposes a four-stage model of NPE. It starts with a sympathetic storm (a massive release of stress hormones), then moves to disruption of the lung's blood vessels, followed by inflammation, and finally a systemic spread involving the gut-lung connection. The model also offers testable predictions, such as which brain lesions might worsen NPE and which nerve pathways could be targeted to reduce fluid buildup.

This is a theoretical framework, not a clinical trial. The review does not provide new data from patients or test any treatments. But it gives researchers a roadmap for future studies, pointing to potential stage-specific interventions like early sympathetic blockade or anti-inflammatory strategies.

For now, this is a step toward better understanding, not a ready-to-use treatment. If you or a loved one is at risk for NPE, talk to a doctor about current management options.

What this means for you:

A new model maps NPE's four stages, guiding future research on targeted treatments.

Common questions

What is neurogenic pulmonary edema?

Neurogenic pulmonary edema (NPE) is a buildup of fluid in the lungs that can happen after a severe brain injury, like a stroke or head trauma. It makes breathing difficult and can be life-threatening. The new model helps explain how it progresses.

What are the four stages of NPE?

The model describes four stages: 1) sympathetic storm initiation, 2) disruption of lung blood vessels, 3) inflammation, and 4) systemic progression involving the gut-lung axis. Each stage offers potential targets for treatment.

Is this model based on patient data?

No. This is a narrative review that proposes a theoretical model based on existing research. It does not include new patient data or clinical trial results. The predictions need to be tested in future studies.

Does this model suggest new treatments?

The model suggests stage-specific interventions, such as early sympathetic blockade or anti-inflammatory strategies. However, these are theoretical and have not been proven in clinical trials. Always consult a doctor for current treatment options.

Study Details

Study typeSystematic review

EvidenceLevel 1

PublishedJul 2026

View Original Abstract ↓

Neurogenic pulmonary edema (NPE) is a life-threatening complication of acute central nervous system (CNS) injury, characterized by the rapid onset of hypoxemia and pulmonary fluid accumulation in the absence of underlying cardiopulmonary disease. In recent years, emerging integrative frameworks such as the “neuroimmunoaxis” and “brain-lung axis” have provided new perspectives on how CNS injury leads to systemic immune dysregulation and pulmonary dysfunction. However, critical questions remain regarding the interplay between excessive sympathetic activation, immune homeostasis disruption, and lung tissue injury. This narrative review proposes a neurotransmitter-immune-inflammatory model that integrates mechanical, adrenergic, and inflammatory pathways across the spatiotemporal evolution of NPE. We identify four progressive stages involving sympathetic storm initiation due to central autonomic network disinhibition, pulmonary vascular barrier disruption through Piezo channel activation and angiotensin II-norepinephrine synergy, inflammatory amplification from loss of the cholinergic anti-inflammatory reflex, and systemic progression involving gut-lung axis dysregulation. The model generates three testable predictions. Lesions disrupting the nucleus tractus solitarius-ventromedial hypothalamus-intermediolateral column projection should produce more severe NPE. And selective activation of TRPA1+ dorsal root ganglion neurons should attenuate sympathetic outflow and pulmonary edema. Enhancing α7 nicotinic acetylcholine receptor signaling should mitigate systemic inflammation. These predictions offer experimental avenues for validating the hijacking hypothesis. Translational implications include stage-specific interventions, early sympathetic blockade, mid-phase anti-inflammatory and neuro-modulatory strategies, and late-stage lung-protective ventilation. This study aims to offer a comprehensive analysis of NPE by exploring its pathological mechanisms—from central sympathetic signaling to peripheral lung damage. Emphasis is placed on examining the interactions between neural signals, neurotransmitters, and immune responses to uncover the spatiotemporal dynamics of NPE. By identifying potential pathways for early diagnosis and targeted therapies, the research seeks to improve disease management and contribute to better clinical outcomes for affected patients.

A four-stage progression model identifies potential targets for neurogenic pulmonary edema managementNew model reveals four stages of neurogenic pulmonary edema

Common questions

Study Details

Intravenous tenecteplase improves functional outcomes but increases hemorrhage risk in non-large vessel occlusion acute ischemic stroke

Tenecteplase improves stroke recovery but increases bleeding risk in late treatment window

Clinical research that matters. Delivered to your inbox.

A four-stage progression model identifies potential targets for neurogenic pulmonary edema managementNew model reveals four stages of neurogenic pulmonary edema

Common questions

Study Details

Intravenous tenecteplase improves functional outcomes but increases hemorrhage risk in non-large vessel occlusion acute ischemic stroke

Tenecteplase improves stroke recovery but increases bleeding risk in late treatment window

Clinical research that matters. Delivered to your inbox.

Related in Neurology

From Other Specialties